135 related articles for article (PubMed ID: 16352484)
1. Gender differences in the treatment and secondary prevention of CHD at population level.
Kattainen A; Salomaa V; Jula A; Antero Kesäniemi Y; Kukkonen-Harjula K; Kähönen M; Majahalme S; Moilanen L; Nieminen MS; Aromaa A; Reunanen A
Scand Cardiovasc J; 2005 Dec; 39(6):327-33. PubMed ID: 16352484
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: a register-based study.
Vehko T; Manderbacka K; Arffman M; Sund R; Reunanen A; Keskimäki I
Scand J Public Health; 2010 May; 38(3):317-24. PubMed ID: 20228159
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Cooke CE; Hammerash WJ
Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
[TBL] [Abstract][Full Text] [Related]
4. Use of secondary preventive medications after the first attack of acute coronary syndrome.
Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
[TBL] [Abstract][Full Text] [Related]
5. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
6. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care.
McGovern MP; Boroujerdi MA; Taylor MW; Williams DJ; Hannaford PC; Lefevre KE; Simpson CR
Fam Pract; 2008 Feb; 25(1):33-9. PubMed ID: 18222938
[TBL] [Abstract][Full Text] [Related]
7. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of coronary heart disease in the elderly.
Dornbrook-Lavender KA; Roth MT; Pieper JA
Ann Pharmacother; 2003 Dec; 37(12):1867-76. PubMed ID: 14632542
[TBL] [Abstract][Full Text] [Related]
9. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
10. Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult CHD patients in Finland: results from a large national database between 2000 and 2006.
Ahola TL; Kantola IM; Puukka P; Kattainen A; Klaukka T; Reunanen A; Jula AM
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):477-85. PubMed ID: 20220527
[TBL] [Abstract][Full Text] [Related]
11. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
[TBL] [Abstract][Full Text] [Related]
12. [Health care quality: medication and prevention in patients with and without coronary heart disease].
Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
[TBL] [Abstract][Full Text] [Related]
13. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s.
Kattainen A; Salomaa V; Härkänen T; Jula A; Kaaja R; Kesäniemi YA; Kähönen M; Moilanen L; Nieminen MS; Aromaa A; Reunanen A
Eur Heart J; 2006 Feb; 27(3):296-301. PubMed ID: 16284204
[TBL] [Abstract][Full Text] [Related]
14. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II).
Mensah GA; Brown DW; Croft JB; Greenlund KJ
Am J Prev Med; 2005 Dec; 29(5 Suppl 1):68-74. PubMed ID: 16389129
[TBL] [Abstract][Full Text] [Related]
15. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
Ko M; Kim MT; Nam JJ
Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
[TBL] [Abstract][Full Text] [Related]
16. Coronary heart disease in China.
Zhang XH; Lu ZL; Liu L
Heart; 2008 Sep; 94(9):1126-31. PubMed ID: 18703693
[TBL] [Abstract][Full Text] [Related]
17. Prevention of coronary heart disease in women.
Loomba RS; Arora R
Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):321-7. PubMed ID: 19124430
[TBL] [Abstract][Full Text] [Related]
18. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
[TBL] [Abstract][Full Text] [Related]
20. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
